British pharma company GlaxoSmithKline (GSK) are to pair up with Eligo Bioscience in a deal potentially worth €185m ($224m) that sees the firms target the microbiome to reduce the risk of developing acne.
GlaxoSmithKline's alli product - which is the only weight
loss drug to directly compete with dietary supplements - has
already become the third top-selling obesity drug less than a year
after its launch.
A petition by drug firm GlaxoSmithKline (GSK) requesting that
weight loss claims be treated as disease claims maintains that
there is no credible science to back up weight loss ingredients
used in dietary supplements.
GlaxoSmithKline's (GSK) Ribena range of juice drinks have been
found to meet their stated claims of high vitamin C content in
Singapore, according to the country's Agri-Food and Veterinary
Australian legislation on nutritional labelling has come under the
spotlight with the announcement by GlaxoSmithKline (GSK) that its
Ribena drinks brand may have misled consumers over the amount of
vitamin C it contains.